Skip to main content

Market Overview

ATEC Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights

Share:

Third Quarter U.S. Revenue Growth of 34% Year-Over-Year
Drives Increase in Full Year 2019 Guidance  

CARLSBAD, Calif., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. ("ATEC" or the "Company") (NASDAQ:ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2019, and recent corporate highlights.

Third Quarter 2019 Financial Results

  • Total net revenue of $29.2 million; U.S. revenue of $28.1 million, up 34% compared to the prior year and up 8% sequentially;
  • U.S. gross margin of 70.8%; and
  • Cash and cash equivalents of $57.8 million as of September 30, 2019.

Third Quarter-to-Date Corporate Highlights

  • Closed a follow-on equity offering that generated $54 million in net proceeds for growth-related investment and expanded the institutional shareholder base;
  • Enhanced clinical distinction with five new product launches: the IdentiTi™ TLIF Porous Oblique System, the IdentiTi™ LIF Systems, the AMP™ Anti-Migration LIF Plate System, the Transcend™ Lateral Interbody Spacer, and the Trestle Luxe® II Anterior Cervical Plate System;
  • Increased contribution from new products to 42% of U.S. revenue;
  • Expanded percentage of U.S. revenue driven by strategic distribution network to 89%;
  • Increased U.S. revenue per case by 17% compared to the prior year; and
  • Expanded senior leadership team by appointing Eric Dasso as Executive Vice President, Adjunctive Technologies.

"Our continued focus on compelling surgeon adoption by creating clinical distinction and revitalizing the ATEC sales channel substantially accelerated organic U.S. revenue growth in the third quarter," said Pat Miles, Chairman and Chief Executive Officer.  "As a result, we are increasing 2019 revenue expectations for the second time this year, now anticipating full-year U.S. revenue growth of over 26%. I'm proud of all that our teams have accomplished to date, and I am even more enthusiastic about the future for spine's new Organic Innovation Machine."

Comparison of Selected GAAP and Non-GAAP Financial Results for the
Third Quarter 2019 to Third Quarter 2018
               
  Three Months Ended   Change
  September 30, 2019   September 30, 2018   $   %
  (unaudited)   (unaudited)        
               
Revenue from U.S. products $ 28,051     $ 20,996     $ 7,055     34 %
Gross profit from U.S. products   19,853       16,001       3,852     24 %
Gross margin from U.S. products   70.8 %     76.2 %        
               
Operating Expenses              
Research and development $ 3,962     $ 3,157     $ 805     25 %
Sales, general and administrative   26,792       18,833       7,959     42 %
Litigation-related expenses   604       1,329       (725 )   (55 %)
Amortization of intangible assets   172       187       (15 )   (8 %)
Transaction-related expenses   -       66       (66 )   (100 %)
Restructuring   -       167       (167 )   (100 %)
Total operating expenses $ 31,530     $ 23,739     $ 7,791     33 %
               
Operating loss $ (11,597 )   $ (7,533 )   $ (4,064 )   54 %
               
Non-GAAP operating loss $ (5,114 )   $ (3,006 )   $ (2,108 )   70 %
               
Non-GAAP adjusted EBITDA $ (3,190 )   $ (1,415 )   $ (1,775 )   125 %
               

 

Revenue from U.S. products for the third quarter 2019 was $28.1 million, up 34% compared to $21.0 million in the third quarter 2018. Revenue growth generated by new products and the strategic distribution channel continues to outpace the ongoing revenue impacts of transitioning or discontinuing non-strategic distributor relationships.

Gross profit and gross margin from U.S. products for the third quarter 2019 were $19.9 million and 70.8%, respectively, compared to $16.0 million and 76.2%, respectively, for the third quarter 2018. U.S. gross margin was impacted by increased non-cash excess and obsolete write-offs related to legacy products. On a non-GAAP basis, excluding non-cash excess and obsolete charges, U.S. gross margin was 78.9% in the third quarter of 2019, compared to 79.8% in the third quarter of 2018.

Total operating expenses for the third quarter 2019 were $31.5 million compared to $23.7 million in the third quarter 2018.  On a non-GAAP basis, excluding stock-based compensation, fair value adjustments, litigation-related expenses, restructuring and transaction-related expenses, total operating expenses increased to $27.4 million from $20.0 million in 2018, reflecting increased selling costs from U.S. revenue growth, as well as increased investments in organic product development to support new product launches.

Non-GAAP adjusted operating loss, which excludes stock-based compensation, fair value adjustments, litigation-related expenses, restructuring, transaction-related expenses and excess and obsolescence charges, was $5.1 million for the third quarter 2019, compared to a loss of $3.0 million for the third quarter 2018. 

Non-GAAP adjusted EBITDA, which excludes stock-based compensation, fair value adjustments, litigation-related expenses, restructuring, transaction-related expenses and excess and obsolescence charges in the third quarter 2019 was a loss of $3.2 million, compared to a loss of $1.4 million in the third quarter 2018. 

For more detailed information on non-GAAP operating expenses, non-GAAP adjusted operating loss and non-GAAP adjusted EBITDA, please refer to the table, "Alphatec Holdings, Inc. Reconciliation of Non-GAAP Financial Measures," that follows.

Current and long-term debt at face value includes $45 million in term debt and $11.6 million outstanding under the Company's revolving credit facility at September 30, 2019, with cash and cash equivalents of $57.8 million.

Updated 2019 Financial Outlook

Full Year 2019 Previous Updated
  Guidance ($M) YoY Growth Guidance ($M) YoY Growth
U.S. Product Revenue $100 to $104 20% to 24% $105 to $107 26% to 28%
International Supply Agreement $4 to $5 (38%) to (50%) No change No change
Total Revenue $104 to $109 13% to 19% $109 to $112 19% to 22%

Investor Conference Call

ATEC will present the results via a live webcast today at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results. At that time, please click here to access the live webcast.  An audiocast of the presentation will be also be available domestically at (877) 556-5251 and internationally at (720) 545-0036. The conference ID number is 6098197.

Non-GAAP Financial Information

To supplement the Company's financial statements presented in accordance with U.S. generally accepted accounting principles (GAAP), the Company reports certain non-GAAP financial measures, including non-GAAP U.S. gross margin, non-GAAP operating expenses, non-GAAP operating loss, and non-GAAP Adjusted EBITDA. The Company believes that these non-GAAP financial measures provide investors with an additional tool for evaluating the Company's core performance, which management uses in its own evaluation of continuing operating performance, and a baseline for assessing the future earnings potential of the Company. The Company's non-GAAP financial measures may not provide information that is directly comparable to that provided by other companies in the Company's industry, as other companies in the industry may calculate non-GAAP financial results differently, particularly related to non-recurring, unusual items. Non-GAAP financial results should be considered in addition to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Included below are reconciliations of the non-GAAP financial measures to the comparable GAAP financial measures.

About Alphatec Holdings, Inc.

Alphatec Holdings, Inc., through its wholly-owned subsidiaries, Alphatec Spine, Inc. and SafeOp Surgical, Inc., is a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery. ATEC designs, develops and markets technology for the treatment of spinal disorders.  The Company markets its products in the U.S. via independent sales agents and a direct sales force.
Additional information can be found at www.atecspine.com.

Forward Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The Company cautions investors that there can be no assurance that actual results or business conditions will not di

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com